C. Guerra, R. Snow, and S. Hay, Mapping the global extent of malaria in 2005, Trends in Parasitology, vol.22, issue.8, pp.353-358, 2005.
DOI : 10.1016/j.pt.2006.06.006

A. Gregson and C. Plowe, Mechanisms of resistance of malaria parasites to antifolates by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy, Pharmacol Rev Infect Immun, vol.57, issue.75, pp.117-145, 2005.

J. Epstein, Y. Charoenvit, and K. Kester, Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A, Vaccine, vol.22, issue.13-14, pp.1592-1603, 2004.
DOI : 10.1016/j.vaccine.2004.01.031

V. Moorthy, E. Imoukhuede, and S. Keating, Phase 1 Evaluation of 3 Highly Immunogenic Prime???Boost Regimens, Including a 12???Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men, The Journal of Infectious Diseases, vol.189, issue.12, pp.2213-2219, 2004.
DOI : 10.1086/421118

R. Wang, J. Epstein, and Y. Charoenvit, Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein, The Journal of Immunology, vol.172, issue.9, pp.5561-5569, 2004.
DOI : 10.4049/jimmunol.172.9.5561

T. Jones, D. Narum, and A. Gozalo, EBA???175 Region II DNA Prime???Protein Boost Immunization Regimen, The Journal of Infectious Diseases, vol.183, issue.2, pp.303-312, 2001.
DOI : 10.1086/317933
URL : http://jid.oxfordjournals.org/cgi/content/short/183/2/303

W. Rogers, W. Weiss, and A. Kumar, Protection of Rhesus Macaques against Lethal Plasmodium knowlesi Malaria by a Heterologous DNA Priming and Poxvirus Boosting Immunization Regimen, Infection and Immunity, vol.70, issue.8, pp.4329-4335, 2002.
DOI : 10.1128/IAI.70.8.4329-4335.2002

K. Ruitenberg, C. Walker, J. Wellington, D. Love, and J. Whalley, DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection, Vaccine, vol.17, issue.3, pp.237-244, 1999.
DOI : 10.1016/S0264-410X(98)00192-3

J. Schneider, S. Gilbert, and T. Blanchard, Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara, Nature Medicine, vol.14, issue.4, pp.397-402, 1998.
DOI : 10.1016/0264-410X(94)90073-6

R. Amara, F. Villinger, and J. Altman, Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine, Science, vol.292, issue.5514, pp.69-74, 2001.
DOI : 10.1126/science.1058915

N. Sullivan, A. Sanchez, P. Rollin, Z. Yang, and G. Nabel, Development of a preventive vaccine for Ebola virus infection in primates, Nature, vol.408, pp.605-609, 2000.

D. Doolan and S. Hoffman, DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation, International Journal for Parasitology, vol.31, issue.8, pp.753-762, 2001.
DOI : 10.1016/S0020-7519(01)00184-9

L. Shan, Combination DNA plus protein HIV vaccines, Springer Semin Immunopathol, vol.28, pp.255-265, 2006.

A. Mehrizi, S. Zakeri, A. Salmanian, M. Sanati, and N. Djadid, IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran, Acta Tropica, vol.112, issue.1, pp.1-7, 2009.
DOI : 10.1016/j.actatropica.2009.05.016
URL : https://hal.archives-ouvertes.fr/pasteur-00751818

S. Zakeri, A. Mehrizi, S. Zoghi, and N. Djadid, Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-119) in Iranians exposed to unstable malaria transmission, Malaria Journal, vol.9, issue.1, p.257, 2010.
DOI : 10.1186/1475-2875-9-257

C. Guerra, P. Gikandi, and A. Tatem, The Limits and Intensity of Plasmodium falciparum Transmission: Implications for Malaria Control and Elimination Worldwide, PLoS Medicine, vol.3, issue.2, p.38, 2008.
DOI : 10.1371/journal.pmed.0050038.st001

J. Baird, Neglect of Plasmodium vivax malaria, Trends in Parasitology, vol.23, issue.11, pp.533-539, 2007.
DOI : 10.1016/j.pt.2007.08.011

V. Chitarra, I. Holm, G. Bentley, S. Petres, and S. Longacre, The Crystal Structure of C-Terminal Merozoite Surface Protein 1 at 1.8 ?? Resolution, a Highly Protective Malaria Vaccine Candidate, Molecular Cell, vol.3, issue.4, pp.457-464, 1999.
DOI : 10.1016/S1097-2765(00)80473-6

M. Rodrigues, M. Gunha, R. Machado, O. Ferreira, M. Rodrigues et al., Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1, Malaria Journal, vol.2, issue.1, p.39, 2003.
DOI : 10.1186/1475-2875-2-39

M. Gardner, D. Doolan, and R. Hedstrom, DNA Vaccines against Malaria: Immunogenicity and Protection in a Rodent Model, Journal of Pharmaceutical Sciences, vol.85, issue.12
DOI : 10.1021/js960147h

D. Doolan, M. Sedegah, R. Hedstrom, P. Hobart, Y. Charoenvit et al., Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity, Journal of Experimental Medicine, vol.183, issue.4, pp.1739-1746, 1996.
DOI : 10.1084/jem.183.4.1739

D. Souza, J. Williamson, K. Otani, T. Playfair, and J. , Early gamma interferon responses in lethal and nonlethal murin blood-stage malaria, Infect Immun, vol.65, pp.1593-1598, 1997.

P. Patterson, S. Bosshardt, and V. Udhayukumar, Prolonged expression of IFN?? induced by protective blood-stage immunization against Plasmodium yoelii malaria, Vaccine, vol.18, issue.1-2, pp.173-180, 1999.
DOI : 10.1016/S0264-410X(99)00217-0

A. Taylor-robinson, R. Phillips, A. Severn, S. Moncada, and F. Liew, The role of TH1 and TH2 cells in a rodent malaria infection, Science, vol.260, issue.5116, pp.1931-1934, 1993.
DOI : 10.1126/science.8100366

R. Gramzinski, D. Doolan, M. Sedegah, H. Davis, A. Krieg et al., Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in Mice, Infection and Immunity, vol.69, issue.3, pp.1643-1649, 2001.
DOI : 10.1128/IAI.69.3.1643-1649.2001

C. Hirunpetcharat, J. Tian, and D. Kaslow, Complete protective immunity induced in mice by immunization with the 19-kilodal- ton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP119) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells, J Immunol, vol.159, pp.3400-3411, 1997.

L. Miller and S. Hoffman, Research toward vaccines against malaria, Nature Medicine, vol.10, issue.5s, pp.520-524, 1998.
DOI : 10.1016/0097-8485(94)85023-2

N. Smith, A. Fell, and M. Good, The Immune Response to Asexual Blood Stages of Malaria Parasites, Chem Immunol, vol.70, pp.144-162, 1998.
DOI : 10.1159/000058704

E. Lee, D. Palmer, and K. Flanagan, Induction of T Helper Type 1 and 2 Responses to 19-Kilodalton Merozoite Surface Protein 1 in Vaccinated Healthy Volunteers and Adults Naturally Exposed to Malaria, Infection and Immunity, vol.70, issue.3, pp.1417-1421, 2002.
DOI : 10.1128/IAI.70.3.1417-1421.2002